Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine
Dynavax will provide CpG 1018 to produce up to 190 million doses over a five year period to support Valneva’s contract with the U.K. government Inactivated, adjuvanted SARS-COV-2 vaccine candidate scheduled to enter first clinical studies in December …